Purple Biotech (PPBT) Institutional Ownership $2.47 -0.15 (-5.73%) (As of 11/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Purple Biotech (NASDAQ:PPBT)CurrentInstitutional OwnershipPercentage9.64%Number ofInstitutional Buyers(last 12 months)3Number ofInstitutional Sellers(last 12 months)1 Get PPBT Insider Trade Alerts Want to know when executives and insiders are buying or selling Purple Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PPBT Institutional Buying and Selling by Quarter Ad Crypto 101 Media“Sleeping Giant” Crypto Set to Explode…What if I told you there's a crypto that could make Bitcoin look like small change? We're looking at potential returns that could rewrite your financial future. Click here to discover our #1 crypto pick before it's too late Purple Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2024 Armistice Capital LLC1,358,000$553K0.0%-35.8%5.381% 2/13/2024 Armistice Capital LLC1,882,173$1.47M0.0%N/A8.544% 2/6/2024 WuXi AppTec Co. Ltd.194,139$151K0.4%N/A0.881% 1/16/2024 Kingswood Wealth Advisors LLC175,100$137K0.0%+34.0%0.795% 8/9/2023 Kingswood Wealth Advisors LLC127,950$178K0.1%N/A0.692% 2/3/2023Fisher Asset Management LLC32,200$44K0.0%N/A0.183% 1/28/2022 ARK Investment Management LLC662,499$2.58M0.0%-10.0%2.554% 11/15/2021 Point72 Asset Management L.P.279,294$1.28M0.0%-46.8%1.077% 10/20/2021 Venture Visionary Partners LLC10,068$46K0.0%N/A0.039% 8/16/2021 Point72 Asset Management L.P.525,000$2.56M0.0%N/A2.024% 8/16/2021 Morgan Stanley37,988$185K0.0%-77.4%0.146% 8/11/2021 Condor Capital Management21,000$102K0.0%N/A0.081% 5/18/2021 Morgan Stanley167,804$693K0.0%-66.1%0.958% 5/18/2021 Orbimed Advisors LLC31,418$130K0.0%-90.9%0.179% 5/13/2021 Renaissance Technologies LLC219,035$905K0.0%+69.9%1.251% 3/26/2021 Susquehanna International Group LLP20,679$79K0.0%N/A0.132% 2/24/2021Virtu Financial LLC22,988$88K0.0%N/A0.146% 2/16/2021 Orbimed Advisors LLC346,197$1.32M0.0%N/A2.202% 2/10/2021 Renaissance Technologies LLC128,900$491K0.0%N/A0.820% 2/8/2021 Washington Trust Bank16,454$63K0.0%N/A0.105% 11/13/2020 Morgan Stanley6,139$27K0.0%+223.4%0.039% (Data available from 1/1/2016 forward) PPBT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PPBT shares? During the previous two years, the following institutional investors and hedge funds held shares of Purple Biotech shares: Armistice Capital LLC ($553K), WuXi AppTec Co. Ltd. ($151K), and Kingswood Wealth Advisors LLC ($137K), Fisher Asset Management LLC ($44K).Learn more on PPBT's institutional investors. What percentage of Purple Biotech stock is owned by institutional investors? 9.64% of Purple Biotech stock is owned by institutional investors. Learn more on PPBT's institutional investor holdings. Which institutional investors have been buying Purple Biotech stock? The following institutional investors have purchased Purple Biotech stock in the last 24 months: Armistice Capital LLC ($1.88M), WuXi AppTec Co. Ltd. ($194.14K), Kingswood Wealth Advisors LLC ($172.40K), and Fisher Asset Management LLC ($32.20K). How much institutional buying is happening at Purple Biotech? Institutional investors have bought a total of 2,280,912 shares in the last 24 months. This purchase volume represents approximately $0.00 in transactions. Which Purple Biotech major shareholders have been selling company stock? The following institutional investors have sold Purple Biotech stock in the last 24 months: Armistice Capital LLC ($757K). How much institutional selling is happening at Purple Biotech? Institutional investors have sold a total of 757,000 shares in the last 24 months. This volume of shares sold represents approximately $0.00 in transactions. Related Companies AIM ImmunoTech Institutional Ownership NLS Pharmaceutics Institutional Ownership Sensei Biotherapeutics Institutional Ownership Sol-Gel Technologies Institutional Ownership Talphera Institutional Ownership Aspira Women's Health Institutional Ownership ImmunoPrecise Antibodies Institutional Ownership NKGen Biotech Institutional Ownership Indaptus Therapeutics Institutional Ownership Turnstone Biologics Institutional Ownership This page (NASDAQ:PPBT) was last updated on 11/20/2024 by MarketBeat.com Staff From Our PartnersTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands...Angel Publishing | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | SponsoredThe smart-money is buying this US$1 lithium stockLithium is getting white-hot once again! And that means well-timed investors who position now in the best n...Resource Stock Digest | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Purple Biotech Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Purple Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
